The pharmaceutical industry is navigating one of its most significant operational transformations in decades. As the Drug Supply Chain Security Act (DSCSA) enforcement period matures, companies are discovering that compliance success hinges on details many initially overlooked—chief among them, how they identify and communicate location data across their trading partner networks.
Continue reading Mastering Location Identification: A Practical Guide to GLN Implementation for Pharma Supply ChainsDISCLAIMER: RxTrace contains some of the personal thoughts, ideas and opinions of RxTrace. The material contained in RxTrace is not legal advice. The writers of RxTrace are not lawyers.
The reader must make their own decisions about the accuracy of the opinions expressed in RxTrace. Readers are encouraged to consult their own legal counsel
and trading partners before taking any actions based on information found in RxTrace. RxTrace is not a vehicle for communicating
the positions of any company, organization or individual other than RxTrace.
RxTrace, a comprehensive exploration of the intersection between healthcare supply chains, track and trace technology, standards and global regulatory compliance.
Contact Us | Privacy Statement
Copyright © 2009-2021 TrackTraceRx, Inc. All Rights Reserved.
RxTrace is a registered trademark of TrackTraceRx, Inc
